相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。AMPK activation, a preventive therapeutic target in the transition from cardiac injury to heart failure
Christophe Beauloye et al.
CARDIOVASCULAR RESEARCH (2011)
Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture
Omar J. Cassol- et al.
BRAIN RESEARCH (2010)
CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes
Partha Mukhopadhyay et al.
CARDIOVASCULAR RESEARCH (2010)
Cannabinoid-Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders
Javier Fernandez-Ruiz et al.
CNS NEUROSCIENCE & THERAPEUTICS (2010)
Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure
Florian Weis et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2010)
Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial
Eric J. Topol et al.
LANCET (2010)
The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction
Shiang Y. Lim et al.
BASIC RESEARCH IN CARDIOLOGY (2009)
Metformin Prevents Progression of Heart Failure in Dogs Role of AMP-Activated Protein Kinase
Hideyuki Sasaki et al.
CIRCULATION (2009)
Reconsidering the Role for Digoxin in the Management of Acute Heart Failure Syndromes
Mihai Gheorghiade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Endocannabinoids and the Heart
C. Robin Hiley
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2009)
Endocannabinoids and cardiac contractile function: Pathophysiological implications
Sandor Batkai et al.
PHARMACOLOGICAL RESEARCH (2009)
Endothelial CB1-receptors limit infarct size through NO formation in rat isolated hearts
Philippe Lepicier et al.
LIFE SCIENCES (2007)
Endocannabinoids acting at CB1 receptors mediate the cardiac contractile dysfunction in vivo in cirrhotic rats
Sandor Batkai et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Pharmacological inhibition of CB1 cannabinoid raceptor protects against doxorubicin-induced cardiotoxicity
Partha Mukhopadhyay et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Review of current and investigational pharmacologic agents for acute heart failure syndromes
David D. Shin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
2-arachidonylglycerol acting on CB1 cannabinoid receptors mediates delayed cardioprotection induced by nitric oxide in rat isolated hearts
Jens A. Wagner et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2006)
Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients - RIO-North America: A randomized controlled trial
F Pi-Sunyer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia
JP Despres et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Coronary vasodilator effects of endogenous cannabinoids in vasopressin-preconstricted unpaced rat isolated hearts
JA Wagner et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Cannabinoids and ghrelin have both central and peripheral metabolic and cardiac effects via AMP-activated protein kinase
B Kola et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice
S Steffens et al.
NATURE (2005)
Characteristics and outcomes of patients hospitalized for heart failure in the United States: Rationale, design, and preliminary observations from the first 100,000, cases in the Acute Decompensated Heart Failure National Registry (ADHERE)
KF Adams et al.
AMERICAN HEART JOURNAL (2005)
Search for an endogenous cannabinoid-mediated effect in the sympathetic nervous system
T Pfitzer et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2005)
Cannabinoid pharmacology in the cardiovascular system: potential protective mechanisms through lipid signalling
CR Hiley et al.
BIOLOGICAL REVIEWS (2004)
Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension
S Bátkai et al.
CIRCULATION (2004)
The peripheral sympathetic nervous system is the major target of cannabinoids in eliciting cardiovascular depression
N Niederhoffer et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2003)
CB1 cannabinoid receptor antagonism promotes remodeling and cannabinoid treatment prevents endothelial dysfunction and hypotension in rats with myocardial infaretion
JA Wagner et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
Contribution of endocannabinoids in the endothelial protection afforded by ischemic preconditioning in the isolated rat heart
JF Bouchard et al.
LIFE SCIENCES (2003)
Endocannabinoids are implicated in the infarct size-reducing effect conferred by heat stress preconditioning in isolated rat hearts
M Joyeux et al.
CARDIOVASCULAR RESEARCH (2002)
Echocardiographic assessment of LV hypertrophy and function in aortic-banded mice: necropsy validation
YL Liao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2002)
Endogenous cannabinoids mediate hypotension after experimental myocardial infarction
JA Wagner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2001)
Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats
N Jamshidi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
An endogenous cannabinoid (2-AG) is neuroprotective after brain injury
D Panikashvili et al.
NATURE (2001)
Involvement of cannabinoids in the cardioprotection induced by lipopolysaccharide
C Lagneux et al.
BRITISH JOURNAL OF PHARMACOLOGY (2001)
分享论文
